Purdue unit targets AUPharma over Targin

Corrs Chambers Westgarth 2023-03-29 4:19 pm By Cindy Cameronne | Sydney

Please login to bookmark

A unit of Purdue Pharma has fired off a cross-claim in Australian drug maker AUPharma’s lawsuit alleging the US drug giant was wrongly granted patent extensions for oxycodone products marketed as Targin.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au